Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · IEX Real-Time Price · USD
1.320
+0.010 (0.76%)
At close: Jul 19, 2024, 4:00 PM
1.280
-0.040 (-3.03%)
Pre-market: Jul 22, 2024, 7:15 AM EDT
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $94.07 million as of July 22, 2024. Its market cap has decreased by -86.96% in one year.
Market Cap
94.07M
Enterprise Value
-34.10M
1-Year Change
-86.96%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has decreased from $214.50M to $94.07M, a decrease of -56.14%. That is a compound annual growth rate of -8.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 94.10M | 26.48% |
| Dec 29, 2023 | 74.40M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.98% |
| Dec 31, 2021 | 890.20M | 220.56% |
| Dec 31, 2020 | 277.70M | 255.12% |
| Dec 31, 2019 | 78.20M | -74.15% |
| Dec 31, 2018 | 302.50M | -60.22% |
| Dec 29, 2017 | 760.40M | 30.72% |
| Dec 30, 2016 | 581.70M | 7.13% |
| Dec 31, 2015 | 543.00M | 153.15% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagimet Biosciences | 98.61M |
| Sensus Healthcare | 98.36M |
| Xtant Medical Holdings | 96.53M |
| Checkpoint Therapeutics | 96.44M |
| Anixa Biosciences | 94.10M |
| 111, Inc. | 93.71M |
| Assembly Biosciences | 93.29M |
| Asensus Surgical | 92.55M |